Biotoxin illness is a broad term for chronic, multi-system sickness triggered by exposure to biological toxins produced by organisms like mold, certain bacteria, algae, and even some marine creatures. The most formally studied version goes by the clinical name Chronic Inflammatory Response Syndrome, or CIRS, a condition characterized by innate immune dysregulation that can affect virtually every organ system simultaneously. While the concept was first described in the late 1990s and has since generated a growing body of peer-reviewed research, it remains one of the more contentious areas in medicine, with sharp disagreements between practitioners who diagnose and treat it and mainstream allergy and immunology organizations that question its validity as a distinct disease.
Where the Toxins Come From
The most commonly discussed trigger for biotoxin illness is exposure to water-damaged buildings. When building materials stay wet for extended periods, they become breeding grounds for a complex ecosystem of mold, bacteria, and their metabolic byproducts. Research examining damaged gypsum board and other construction materials has identified colonies of Stachybotrys chartarum (the notorious “black mold”), along with Penicillium and Aspergillus species, gram-negative bacteria, and mycobacteria growing in high concentrations on water-damaged surfaces.1PubMed Central. Bacteria, molds, and toxins in water-damaged building materials These organisms produce mycotoxins, and studies of crude building materials from water-damaged structures have detected trichothecenes (including satratoxins), sterigmatocystin, and citrinine in a significant percentage of samples tested.2PubMed Central. Mycotoxins in crude building materials from water-damaged buildings
Mold is not the only biological source. Ciguatera toxin, produced by marine dinoflagellates and accumulated in reef fish, can trigger a similar chronic inflammatory syndrome after fish consumption. Researchers studying chronic ciguatera have documented the same pattern of inflammatory markers and neuropeptide dysregulation seen in mold-exposed patients.3Neurotoxicology and Teratology. Defining the neurotoxin derived illness chronic ciguatera using markers of chronic systemic inflammatory disturbances: A case/control study Cyanobacteria, the blue-green algae found in contaminated freshwater, produce another biotoxin called BMAA that has been linked to neurodegenerative conditions, including a form of ALS observed in certain populations with chronic exposure.4PubMed Central. The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells Lyme disease, caused by the spirochete Borrelia burgdorferi, is sometimes grouped under the biotoxin illness umbrella as well, since the organism produces compounds that some researchers believe trigger a similar immune cascade in susceptible people.
Why Some People Get Sick and Others Don’t
One of the most perplexing features of biotoxin illness is that two people can share the same water-damaged office or home and have wildly different outcomes. One person walks away fine; the other develops debilitating, chronic symptoms. The prevailing explanation among CIRS researchers centers on genetic variation in the human leukocyte antigen (HLA) system, which plays a central role in how the immune system identifies and clears foreign substances.
Certain HLA-DR and HLA-DQ gene variants appear to impair the body’s ability to tag and remove mycotoxins and other biotoxins from the system. Case reports have documented that individuals carrying these alleles are “poor eliminators” of mycotoxins, meaning the toxins persist in the body and continue provoking immune responses long after exposure has stopped.5PubMed. HLA gene variations and mycotoxin toxicity: Four case reports Some estimates from CIRS practitioners suggest that roughly a quarter of the population carries HLA types that confer susceptibility, though this figure comes from clinical observation rather than large epidemiological studies. A person without these genetic variants can typically clear the toxins through normal immune processing; a person with them may develop a self-perpetuating cycle of inflammation even after leaving the exposure environment.
The Symptom Picture
Biotoxin illness does not behave like a typical infection or allergy. Rather than producing one or two symptoms tied to a single organ, it tends to scatter complaints across multiple body systems at once, which is part of why it goes unrecognized or misdiagnosed so often. CIRS has been characterized as a “multi-system, multi-symptom illness” that can mimic or overlap with conditions like fibromyalgia, chronic fatigue syndrome, anxiety disorders, and autoimmune diseases.6International Journal of Current Science Research and Review. Chronic Inflammatory Response Syndrome (CIRS): A Review of Diagnosis, Immunological Mechanisms and Treatment Challenges
Commonly reported symptoms include:
- Cognitive: difficulty concentrating, word-finding problems, memory loss, and disorientation (sometimes called “brain fog”)
- Neurological: headaches, numbness and tingling, vertigo, light sensitivity, and tremors
- Respiratory: chronic cough, shortness of breath, sinus congestion, and air hunger
- Musculoskeletal: joint pain, muscle aches, cramping, and unusual weakness
- Gastrointestinal: abdominal pain, diarrhea, and appetite changes
- General: profound fatigue, temperature dysregulation, excessive thirst, frequent urination, and static shocks
The static shocks might sound odd, but they turn up frequently in CIRS patient histories and are thought to relate to disrupted regulation of antidiuretic hormone, which affects fluid and electrolyte balance. The sheer breadth of symptoms is itself a distinguishing feature: patients with biotoxin illness often report eight, ten, or more concurrent symptoms spanning different organ systems, a pattern that leads many physicians to suspect psychosomatic illness rather than a unifying physical cause.
What Happens Inside the Body
In a susceptible person, biotoxin exposure sets off a chain reaction in the innate immune system. Because the body cannot properly identify and clear the toxin through the normal antigen-presentation pathway, the immune system stays activated indefinitely, producing escalating levels of inflammatory markers. Research on both mold-exposed and ciguatera-exposed patients has documented elevated levels of TGF beta-1, matrix metalloproteinase-9 (MMP-9), and the complement fragment C4a, all signs of widespread, systemic inflammation.3Neurotoxicology and Teratology. Defining the neurotoxin derived illness chronic ciguatera using markers of chronic systemic inflammatory disturbances: A case/control study
This chronic inflammation disrupts hormone regulation in the hypothalamus, the brain region that controls many basic body functions. A consistent finding in CIRS patients is abnormally low levels of alpha-melanocyte stimulating hormone (MSH), a neuropeptide that normally helps regulate inflammation, gut function, and antimicrobial defenses. Alongside low MSH, many patients show abnormally high leptin levels, which may explain why fatigue and weight gain are such common complaints.7PubMed. A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings The low MSH creates its own downstream problem: it allows antibiotic-resistant bacteria called MARCoNS (multiple antibiotic resistant coagulase-negative staphylococci) to colonize the nasal passages, which further suppresses MSH and feeds the cycle. Research has found that patients who successfully clear MARCoNS show significant increases in circulating MSH compared to those who remain colonized.8PubMed Central. Clearance of multiple antibiotic-resistant coagulase-negative staphylococci is selectively associated with higher circulating α-melanocyte stimulating hormone in patients evaluated for chronic inflammatory response syndrome
At the cellular level, mycotoxins appear to damage mitochondria directly. Laboratory research has shown that aflatoxins can create mitochondrial DNA damage, disrupt the internal membrane structure, and trigger cell death. Trichothecenes cause oxidative stress and interfere with protein and DNA synthesis. Ochratoxin A, another common mycotoxin, impairs the electron transport chain that mitochondria rely on to produce energy.9PubMed Central. Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome This mitochondrial damage offers one explanation for the crushing fatigue that defines the illness for many patients. When cells cannot produce energy efficiently, every system suffers.
Effects on the Brain
The neurological symptoms of biotoxin illness are not just subjective complaints. Brain imaging studies using volumetric MRI have found measurable structural differences in CIRS patients compared to healthy controls. In one study, patients exposed to water-damaged buildings showed significant atrophy of the caudate nucleus, a brain region involved in learning and memory, along with enlargement of the pallidum, the left amygdala, and the right forebrain. The researchers proposed that chronic systemic inflammation increases the permeability of the blood-brain barrier, allowing inflammatory molecules that are normally kept out of the central nervous system to enter and cause tissue damage.10PubMed. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant®
These findings are part of what makes biotoxin illness so alarming to patients and practitioners who take it seriously. Cognitive symptoms like memory loss and difficulty thinking clearly are not merely annoying; they may reflect actual brain volume changes. The good news, reported anecdotally by CIRS clinicians, is that some of these structural changes appear to partially reverse with successful treatment, though large controlled studies tracking brain recovery over time are still lacking.
How It Gets Diagnosed
There is no single blood test that definitively diagnoses biotoxin illness, which contributes to the controversy surrounding it. Instead, CIRS practitioners use a combination of symptom questionnaires, visual contrast sensitivity (VCS) testing, and panels of inflammatory biomarkers.
VCS testing measures your ability to detect differences in shading and contrast, a function that appears to be impaired by the neurotoxic effects of biotoxin exposure. Recent research comparing four different VCS testing methods found that digital tests could reliably distinguish between biotoxin-exposed individuals and controls, with one experimental digital VCS test achieving perfect sensitivity and reasonably good specificity. The older handheld Shoemaker chart, however, did not distinguish between the groups, suggesting that the specific testing method matters quite a bit.11PubMed Central. Assessment of visual contrast sensitivity in biotoxin-exposed individuals using four testing methods VCS testing alone does not confirm CIRS, but it serves as an inexpensive screening tool that can flag patients for further workup.
The biomarker panel used in CIRS evaluation typically includes some or all of the inflammatory markers discussed earlier: C4a, TGF beta-1, MMP-9, MSH, vasoactive intestinal peptide (VIP), leptin, and others. Practitioners look for a characteristic pattern of abnormalities rather than a single out-of-range value. Nasal swabs for MARCoNS are also commonly performed. Some clinicians use urinary mycotoxin testing, though this remains one of the more debated diagnostic tools in the field.
Treatment Approaches
The most widely referenced treatment framework for biotoxin illness is a sequential protocol that moves through a series of steps, each building on the previous one. The approach typically begins with the most obvious intervention: removing the patient from the source of exposure. No treatment works well if the person keeps inhaling mycotoxins from a moldy home or workplace. Environmental remediation or relocation is considered step zero.
After removal from exposure, the protocol generally involves cholestyramine (CSM) or similar bile acid sequestrants. These medications were originally designed to lower cholesterol, but they bind to biotoxins in the gut and help eliminate them from the body. A time-series study of patients with sick building syndrome found CSM to be an effective therapeutic agent, with improvements tracked through both symptom reduction and recovery of visual contrast sensitivity.7PubMed. A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings
Subsequent steps address the various downstream effects of the inflammatory cascade: treating MARCoNS colonization in the nasal passages, correcting hormonal abnormalities, reducing specific inflammatory markers, and addressing any autoimmune activation. For patients who remain symptomatic after completing these earlier steps, the final stage involves vasoactive intestinal peptide (VIP), administered as a nasal spray. In a small open-label trial, VIP nasal spray reduced refractory symptoms to control levels, corrected inflammatory parameters, raised levels of both VIP and MSH, normalized pulmonary artery pressures during exercise, and significantly increased regulatory T cells.12Health. Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings VIP is described as having a broad restorative effect because it modulates the immune system rather than simply suppressing it.13Medical Research Archives. The CIRS Protocol: A Sequential, Evidence-Based Treatment for Biotoxin-Associated Chronic Inflammatory Response Syndrome
It is worth noting that the sequential nature of the protocol matters. Practitioners emphasize that skipping ahead to VIP without addressing MARCoNS or ongoing exposure is ineffective and potentially counterproductive. Each step is designed to remove a layer of the inflammatory cycle so that subsequent interventions can work.
The Controversy
Biotoxin illness occupies an unusual position in medicine. A growing body of peer-reviewed research supports the existence of measurable immune dysregulation, structural brain changes, and characteristic biomarker patterns in exposed patients. At the same time, significant parts of the mainstream medical establishment remain skeptical, sometimes sharply so.
A review published in a leading allergy and immunology journal stated bluntly that “the existence of toxic mold syndrome has been disproven” and characterized common diagnostic practices like home mold spore testing, urinary mycotoxin measurement, and mold-specific IgG testing as lacking validation or clinical relevance.14PubMed. The Myth of Mycotoxins and Mold Injury This represents the position of much of conventional allergy and immunology: that while mold exposure can clearly cause allergic responses and irritation in some people, the broader “chronic inflammatory” model is unproven.
CIRS researchers counter that the mainstream criticism is directed at oversimplified versions of the illness, such as “toxic mold syndrome,” and misses the more nuanced immunological model involving HLA susceptibility, innate immune activation, and neuropeptide dysregulation. They point to the biomarker data, the brain imaging findings, and the measurable treatment responses as evidence that something real and reproducible is happening in these patients. The condition has been explicitly described as “emerging and controversial,” with researchers acknowledging that the evidence base, while growing, still consists largely of small studies, case series, and open-label trials rather than the large randomized controlled trials that would settle the debate.6International Journal of Current Science Research and Review. Chronic Inflammatory Response Syndrome (CIRS): A Review of Diagnosis, Immunological Mechanisms and Treatment Challenges
For patients, this scientific tug-of-war has real consequences. Many report seeing five, ten, or more physicians before receiving a CIRS diagnosis, and some encounter outright dismissal. Insurance coverage for CIRS-related testing and treatment varies widely and is often denied. The disconnect between the patient experience and the official stance of major medical organizations leaves many people in a frustrating limbo.
Mold Illness in Children
While most of the CIRS literature focuses on adults, children are exposed to water-damaged buildings too, and some clinicians report seeing biotoxin illness in pediatric patients. Children present a particular challenge because they may not be able to articulate symptoms like brain fog or air hunger, and their complaints can be attributed to behavioral issues or anxiety. In some cases, biotoxin illness in children has been observed alongside neurobehavioral conditions such as PANS and PANDAS, autoimmune conditions that cause sudden-onset neuropsychiatric symptoms. A case report described a child with overlapping diagnoses of PANS/PANDAS, Lyme disease, and CIRS, highlighting how these conditions can intersect and complicate both diagnosis and treatment.15Journal of Camel Practice and Research. Exploring Structured Camel Milk Therapy Alongside an Individualised Botanical Support Protocol to Facilitate Immune Modulation in a Child Diagnosed with PANS/PANDAS Co-Morbid with Lyme Disease and Autism Pediatric cases underscore why household mold remediation matters for the whole family, not just the adult who happens to be symptomatic.
Living with a Water-Damaged Building
If biotoxin illness starts with exposure, the practical question for many people is whether their home or workplace is the problem. Water damage is far more common than people realize. Leaky roofs, poorly ventilated bathrooms, flooding, and even slow plumbing leaks behind walls can create enough sustained moisture for mold and bacterial colonization. The organisms that produce mycotoxins do not need visible standing water; persistent dampness in drywall, carpet backing, or ceiling tiles is enough. Studies of water-damaged building materials have identified substantial mycotoxin contamination in materials that did not necessarily look dramatically moldy to the naked eye.2PubMed Central. Mycotoxins in crude building materials from water-damaged buildings
Professional mold inspection goes beyond surface swabs. Comprehensive assessment may include air sampling, dust analysis, and moisture mapping of walls and floors. If significant contamination is found, remediation typically involves removing and replacing affected materials, fixing the water source, and thoroughly cleaning the space. Some CIRS practitioners recommend that patients with confirmed susceptibility avoid returning to a previously contaminated space even after remediation, since mycotoxins can persist in settled dust and be difficult to fully eliminate.
For renters, the situation is especially tricky. Landlord-tenant laws regarding mold vary by jurisdiction, and proving that a health condition is caused by a specific building is legally difficult. Documenting visible mold, moisture problems, and a timeline of symptom onset can be important both for medical evaluation and any eventual legal or housing dispute. Some patients find that their symptoms improve dramatically within days of leaving a contaminated building, which, while not proof of causation, provides a powerful personal signal that the environment was a contributing factor.
Mycotoxins and Chronic Fatigue
The overlap between biotoxin illness and chronic fatigue syndrome (CFS) has drawn attention from researchers investigating whether some cases of CFS have an environmental trigger that has been overlooked. Mycotoxins were detected in the urine of a significant proportion of patients with chronic fatigue syndrome in one study, and the researchers linked the fatigue to mitochondrial damage caused by the toxins.9PubMed Central. Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome This does not mean that all chronic fatigue is caused by mold. But for a subset of CFS patients, especially those living or working in buildings with known water damage, the possibility of mycotoxin exposure as a treatable underlying cause is worth investigating.
The mitochondrial angle also connects biotoxin illness to the broader conversation about environmental toxins and energy metabolism. Conditions as varied as Gulf War illness, multiple chemical sensitivity, and post-infectious fatigue syndromes have all been associated, at least in some research, with mitochondrial dysfunction. Whether these represent distinct diseases or overlapping expressions of the same immune-metabolic disruption remains an open and genuinely interesting question that future research may help resolve.